Cargando…
Large-scale pharmacological profiling of 3D tumor models of cancer cells
The discovery of chemotherapeutic agents for the treatment of cancer commonly uses cell proliferation assays in which cells grow as two-dimensional (2D) monolayers. Compounds identified using 2D monolayer assays often fail to advance during clinical development, most likely because these assays do n...
Autores principales: | Mathews Griner, Lesley A, Zhang, Xiaohu, Guha, Rajarshi, McKnight, Crystal, Goldlust, Ian S, Lal-Nag, Madhu, Wilson, Kelli, Michael, Sam, Titus, Steve, Shinn, Paul, Thomas, Craig J, Ferrer, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5261027/ https://www.ncbi.nlm.nih.gov/pubmed/27906188 http://dx.doi.org/10.1038/cddis.2016.360 |
Ejemplares similares
-
mQC: A Heuristic Quality-Control Metric for High-Throughput Drug Combination Screening
por: Chen, Lu, et al.
Publicado: (2016) -
High-throughput matrix screening identifies synergistic and antagonistic antimalarial drug combinations
por: Mott, Bryan T., et al.
Publicado: (2015) -
Chemical Screens Identify Drugs that Enhance or Mitigate Cellular Responses to Antibody-Toxin Fusion Proteins
por: Antignani, Antonella, et al.
Publicado: (2016) -
Selective targeting of JAK/STAT signaling is potentiated by Bcl-xL blockade in IL-2-dependent adult T-cell leukemia
por: Zhang, Meili, et al.
Publicado: (2015) -
High-throughput and targeted drug screens identify pharmacological candidates against MiT-translocation renal cell carcinoma
por: Lang, Martin, et al.
Publicado: (2023)